Tuberculosis News and Research

Latest Tuberculosis News and Research

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

In a new study, exhaled aerosols were compared between infected SARS-CoV-2 patients and healthy controls for the first time. A preprint version of this study, which is yet to undergo peer review, is available on the medRxiv* server.

24 Jan 2022

Novel SARS-CoV-2 mutations reported in chronic HIV patients

A new study describes the emergence of new SARS-CoV-2 variants in three immunocompromised patients.

23 Jan 2022

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

A recent review discusses the engineering versatility of polymeric nanoparticles - making a good therapeutic alternative against coronavirus diseases.

19 Jan 2022

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Researchers observe changes in COVID-19-related deaths during the fourth wave of the COVID-19 pandemic in South Africa.

16 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

A common framework that standardizes health impact across diseases and their interventions can aid in identifying current shortcomings on a global scale, according to new research from Binghamton University, State University of New York.

11 Jan 2022

Simple health assessment could significantly reduce the global burden of COPD

The global burden of Chronic Obstructive Pulmonary Disease (COPD), a group of common lung conditions that affects more than 300 million people, could be significantly reduced with a simple health assessment, concludes a large-scale international study led by UCL researchers.

11 Jan 2022

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

While the world has celebrated the arrival of highly effective vaccines against COVID-19, new work by researchers at Weill Cornell Medicine and the University of Oxford shows that even unrelated vaccines could help reduce the burden of the pandemic.

10 Jan 2022

Researchers identify how a critical schistosomiasis drug works on the molecular level

Independent teams from Texas Biomedical Research Institute and the Medical College of Wisconsin have published two papers in Science Translational Medicine identifying how the only approved drug to treat schistosomiasis, a widespread parasitic worm infection, works on the molecular level.

6 Jan 2022

UK emergency aid to help vulnerable countries tackle the Omicron variant

Foreign Secretary Liz Truss has pledged up to £105 million of UK emergency aid to help vulnerable countries tackle the Omicron Covid-19 variant, with a particular focus on Africa.

30 Dec 2021

Pediatric hospital admissions rise with omicron SARS-CoV-2 variant

A new study examines the impact of the Omicron variant on hospitalizations among children in South Africa.

23 Dec 2021

Mapping access to HIV care

In this interview, we speak to Professor Diego Cuadros about his latest research in which he mapped individuals' access to HIV care in Africa.

23 Dec 2021

Promising new drug target for TB identified

Mycobacterium tuberculosis (Mtb), the hardy bacterial species that causes tuberculosis (TB), has an unexpected vulnerability that future drugs may be able to exploit, according to a study from researchers at Weill Cornell Medicine.

21 Dec 2021

Study casts light on how to combine antibiotics and phage therapy to fight bacterial infection

New research has moved a step closer to harnessing viruses to fight bacterial infection, reducing the threat of antibiotic resistance.

20 Dec 2021

Traditional medicinal plant alleviates malaria symptoms in mice

The active plant ingredient anemonin could provide a new approach in the treatment of malaria. It was identified by researchers from Ethiopia and Germany in a buttercup that is traditionally used in some African countries as a medicinal plant to treat malaria.

20 Dec 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

Study compares exhaled aerosols in SARS-CoV-2 infected individuals and healthy controls

Novel SARS-CoV-2 mutations reported in chronic HIV patients

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

How did the COVID pandemic affect the spread of other zoonotic diseases?

Common framework evaluates the global health impact of drugs and aids in identifying shortcomings

Simple health assessment could significantly reduce the global burden of COPD

Unrelated vaccines could also help reduce the burden of COVID-19 pandemic, study shows

Researchers identify how a critical schistosomiasis drug works on the molecular level

UK emergency aid to help vulnerable countries tackle the Omicron variant

Pediatric hospital admissions rise with omicron SARS-CoV-2 variant

Mapping access to HIV care

Promising new drug target for TB identified

Study casts light on how to combine antibiotics and phage therapy to fight bacterial infection

Traditional medicinal plant alleviates malaria symptoms in mice

PET scans can be used to see drug movement in the body to better treat bacterial infections

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Researchers spot signs of 'pre-resistance' in bacteria for the first time

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

SARS-CoV-2 transmission through indoor aerosols

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in